<DOC>
	<DOCNO>NCT00816803</DOCNO>
	<brief_summary>This study design assess safety autologous bone marrow derive cell transplant chronic spinal cord injury patient . The hypothesis availability bone marrow derive mesenchymal stem cell sit injury promote neuronal regeneration .</brief_summary>
	<brief_title>Cell Transplant Spinal Cord Injury Patients</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Traumatic spinal cord injury No concomitant systemic disease No progress physiotherapy least 6 month Duration injury 10 month 3 year Nontraumatic spinal cord injury whether transverse myelitis demyelination Concomitant systemic disease Progress observe physiotherapy Acute injury duration injury le 10 month</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Spinal cord injury</keyword>
</DOC>